S&P 500   4,605.21 (+0.02%)
DOW   36,266.74 (+0.05%)
QQQ   393.06 (+0.23%)
AAPL   193.05 (-1.36%)
MSFT   368.42 (-1.55%)
META   324.94 (-2.35%)
GOOGL   132.54 (-1.81%)
AMZN   144.40 (-2.05%)
TSLA   242.86 (-0.40%)
NVDA   470.73 (-0.91%)
NIO   7.49 (+1.49%)
BABA   70.58 (-2.16%)
AMD   129.62 (+0.54%)
T   16.79 (-0.77%)
F   11.04 (+0.27%)
MU   77.11 (+2.87%)
CGC   0.77 (-3.51%)
GE   120.68 (+0.07%)
DIS   92.94 (+0.13%)
AMC   6.89 (-0.58%)
PFE   28.58 (-0.69%)
PYPL   59.66 (+1.22%)
XOM   99.07 (-0.48%)
S&P 500   4,605.21 (+0.02%)
DOW   36,266.74 (+0.05%)
QQQ   393.06 (+0.23%)
AAPL   193.05 (-1.36%)
MSFT   368.42 (-1.55%)
META   324.94 (-2.35%)
GOOGL   132.54 (-1.81%)
AMZN   144.40 (-2.05%)
TSLA   242.86 (-0.40%)
NVDA   470.73 (-0.91%)
NIO   7.49 (+1.49%)
BABA   70.58 (-2.16%)
AMD   129.62 (+0.54%)
T   16.79 (-0.77%)
F   11.04 (+0.27%)
MU   77.11 (+2.87%)
CGC   0.77 (-3.51%)
GE   120.68 (+0.07%)
DIS   92.94 (+0.13%)
AMC   6.89 (-0.58%)
PFE   28.58 (-0.69%)
PYPL   59.66 (+1.22%)
XOM   99.07 (-0.48%)
S&P 500   4,605.21 (+0.02%)
DOW   36,266.74 (+0.05%)
QQQ   393.06 (+0.23%)
AAPL   193.05 (-1.36%)
MSFT   368.42 (-1.55%)
META   324.94 (-2.35%)
GOOGL   132.54 (-1.81%)
AMZN   144.40 (-2.05%)
TSLA   242.86 (-0.40%)
NVDA   470.73 (-0.91%)
NIO   7.49 (+1.49%)
BABA   70.58 (-2.16%)
AMD   129.62 (+0.54%)
T   16.79 (-0.77%)
F   11.04 (+0.27%)
MU   77.11 (+2.87%)
CGC   0.77 (-3.51%)
GE   120.68 (+0.07%)
DIS   92.94 (+0.13%)
AMC   6.89 (-0.58%)
PFE   28.58 (-0.69%)
PYPL   59.66 (+1.22%)
XOM   99.07 (-0.48%)
S&P 500   4,605.21 (+0.02%)
DOW   36,266.74 (+0.05%)
QQQ   393.06 (+0.23%)
AAPL   193.05 (-1.36%)
MSFT   368.42 (-1.55%)
META   324.94 (-2.35%)
GOOGL   132.54 (-1.81%)
AMZN   144.40 (-2.05%)
TSLA   242.86 (-0.40%)
NVDA   470.73 (-0.91%)
NIO   7.49 (+1.49%)
BABA   70.58 (-2.16%)
AMD   129.62 (+0.54%)
T   16.79 (-0.77%)
F   11.04 (+0.27%)
MU   77.11 (+2.87%)
CGC   0.77 (-3.51%)
GE   120.68 (+0.07%)
DIS   92.94 (+0.13%)
AMC   6.89 (-0.58%)
PFE   28.58 (-0.69%)
PYPL   59.66 (+1.22%)
XOM   99.07 (-0.48%)

Elanco Animal Health (ELAN) Stock Forecast & Price Target

$12.75
-0.05 (-0.39%)
(As of 09:39 AM ET)
Compare
Today's Range
$12.72
$12.81
50-Day Range
$8.59
$12.87
52-Week Range
$7.88
$14.69
Volume
69,255 shs
Average Volume
6.59 million shs
Market Capitalization
$6.28 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.75

Elanco Animal Health Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 6 Analyst Ratings

Analysts' Consensus Price Target

$13.75
7.84% Upside
High Forecast$18.00
Average Forecast$13.75
Low Forecast$9.50
TypeCurrent Forecast
12/11/22 to 12/11/23
1 Month Ago
11/11/22 to 11/11/23
3 Months Ago
9/12/22 to 9/12/23
1 Year Ago
12/11/21 to 12/11/22
Consensus Rating
Hold
Hold
Hold
Reduce
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
6 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$13.75$12.50$15.10$17.83
Predicted Upside7.84% Upside19.43% Upside27.92% Upside24.78% Upside
Get Elanco Animal Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter.


ELAN Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ELAN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Elanco Animal Health Stock vs. The Competition

TypeElanco Animal HealthMedical CompaniesS&P 500
Consensus Rating Score
2.17
2.67
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside4.09% Upside733.18% Upside13.58% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/7/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$12.00 ➝ $13.00+1.96%
12/7/2023BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$18.00+39.86%
11/13/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$11.00 ➝ $12.00+13.74%
11/8/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$17.00 ➝ $16.00+47.47%
8/8/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSell ➝ Sell$8.50 ➝ $9.50-21.36%
4/20/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeEqual Weight ➝ Overweight$14.00+47.99%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 08:25 AM ET.












ELAN Price Target - Frequently Asked Questions

What is Elanco Animal Health's consensus rating and price target?

According to the issued ratings of 6 analysts in the last year, the consensus rating for Elanco Animal Health stock is Hold based on the current 1 sell rating, 3 hold ratings and 2 buy ratings for ELAN. The average twelve-month price prediction for Elanco Animal Health is $13.75 with a high price target of $18.00 and a low price target of $9.50. Learn more on ELAN's analyst rating history.

Do Wall Street analysts like Elanco Animal Health more than its competitors?

Analysts like Elanco Animal Health less than other Medical companies. The consensus rating for Elanco Animal Health is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how ELAN compares to other companies.

Does Elanco Animal Health's stock price have much upside?

According to analysts, Elanco Animal Health's stock has a predicted upside of 20.33% based on their 12-month stock forecasts.

What analysts cover Elanco Animal Health?

Elanco Animal Health has been rated by BNP Paribas, Morgan Stanley, Piper Sandler, and Stifel Nicolaus in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:ELAN) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -